Colombian experience in the management of hepatitis C
Voir/ Ouvrir
Date
2020-06-29Auteur(s) d'entreprise
Pontificia Universidad Javeriana. Facultad de Medicina. Departamento de Epidemiología Clínica y Bioestadística
Type
Artículo de revista
ISSN
1478-3223 / 1478-3231 (Electrónico)
COAR
Carta al editorPartager cet enregistrement
Citación
Metadata
Afficher la notice complète
Documents PDF
Abstrait
In a past issue of the journal, Schroeder et al.1
discuss the experience and prospects of hepatitis C in
different countries; Colombia, however, was left out. Our country has had an agreement with the
Pan American Health Organization (PAHO) since 2010 to participate in a regional fund for the
acquisition of strategic public health products. Hepatitis C medications were being bought at high
prices, with generic medicines at the same level as original products. Health insurers would
independently purchase their medications at high market prices, expecting reimbursement from the
government.
Lien vers la ressource
https://onlinelibrary.wiley.com/doi/epdf/10.1111/liv.14582Origine
Liver international; Volumen 40 Número 12 , Página 3143 (2020)
Google Analytics Statistics
Collections
- Artículos [682]